Lv1
85 积分 2020-12-12 加入
Tumor Lysis Syndrome
3天前
已完结
Tumor Lysis Syndrome
4天前
已完结
Tumour lysis syndrome
4天前
已完结
Emergencies in haematology: tumour lysis syndrome
4天前
已完结
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research
3个月前
已完结
State of the art and perspectives of CAR-T cell therapy for neuroblastoma
3个月前
已关闭
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
3个月前
已完结
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes
4个月前
已完结
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma
4个月前
已完结
Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab
9个月前
已完结
皖公网安备34019202002308
